Piquette RK |
Torsade de pointes induced by cisapride/clarithromycin interaction. |
1999 |
Ann Pharmacother |
pmid:9972380
|
Yonemochi E et al. |
Physicochemical properties of amorphous clarithromycin obtained by grinding and spray drying. |
1999 |
Eur J Pharm Sci |
pmid:9971917
|
Desta Z et al. |
Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6). |
1999 |
Clin. Pharmacol. Ther. |
pmid:9951426
|
Principi N and Esposito S |
Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients. |
1999 |
Drug Saf |
pmid:9935275
|
Lindeboom JA et al. |
Clarithromycin as a single-modality treatment in mycobacterial avium-intracellular infections. |
1999 |
Oral Surg Oral Med Oral Pathol Oral Radiol Endod |
pmid:9927080
|
GarcÃa-Arata MI et al. |
Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin. |
1999 |
Antimicrob. Agents Chemother. |
pmid:9925537
|
Stefansson P et al. |
Cefuroxime axetil versus clarithromycin in the treatment of acute maxillary sinusitis. |
1998 |
Rhinology |
pmid:9923060
|
Matsushima T and Miyashita N |
[Basic and clinical study of Chlamydia pneumoniae infections]. |
1998 |
Nippon Naika Gakkai Zasshi |
pmid:9922675
|
Kuipers EJ and Klinkenberg-Knol EC |
Helicobacter pylori, acid, and omeprazole revisited: bacterial eradication and rebound hypersecretion. |
1999 |
Gastroenterology |
pmid:9922329
|
Lind T et al. |
The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. |
1999 |
Gastroenterology |
pmid:9922303
|
Garrido A et al. |
[Eradication of Helicobacter pylori by triple therapy in ulcerous patients: the role of endoscopy and antibiotic sensitivity]. |
1998 |
Enferm. Infecc. Microbiol. Clin. |
pmid:9918994
|
Miglioli PA et al. |
Antibacterial activity of human pleural fluid: alone and in combination with antibiotics. |
1998 |
Int. J. Antimicrob. Agents |
pmid:9916908
|
Fera MT et al. |
Bactericidal activity of lansoprazole and three macrolides against Helicobacter pylori strains tested by the time-kill kinetic method. |
1998 |
Int. J. Antimicrob. Agents |
pmid:9916902
|
Lacy MK et al. |
Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and ceruroxime axetil against Streptococcus pneumoniae. |
1998 |
Int. J. Antimicrob. Agents |
pmid:9916901
|
Abe M et al. |
A case of diffuse panbronchiolitis effectively treated with low-dose macrolide antibiotics and leukotriene D4/E4 receptor antagonist. |
1998 |
Respir Med |
pmid:9893782
|
Savarino V et al. |
Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:9892878
|
Einarson A et al. |
A prospective controlled multicentre study of clarithromycin in pregnancy. |
1998 |
Am J Perinatol |
pmid:9890248
|
Lygren I et al. |
[Treatment of Helicobacter pylori infection]. |
1998 |
Tidsskr. Nor. Laegeforen. |
pmid:9889634
|
Williams SL et al. |
Development of a firefly luciferase-based assay for determining antimicrobial susceptibility of Mycobacterium avium subsp. paratuberculosis. |
1999 |
J. Clin. Microbiol. |
pmid:9889208
|
Baena DÃez JM et al. |
[Treatment with omeprazole, clarithromycin and amoxicillin for one week. Their efficacy and tolerance in eradicating Helicobacter pylori in primary care]. |
1998 |
Aten Primaria |
pmid:9887574
|